Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy

RAICHUR, India & BARCELONA, Spain--(BUSINESS WIRE)-- #CNStherapeutics--Shilpa Medicare Ltd has entered a strategic equity partnership with Gate2Brain, S.L., a biotechnology company focused on CNS therapeutics.